These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9367845)

  • 1. Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines.
    Spindler SA; Sarkar FH; Sakr WA; Blackburn ML; Bull AW; LaGattuta M; Reddy RG
    Biochem Biophys Res Commun; 1997 Oct; 239(3):775-81. PubMed ID: 9367845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF.
    Reddy N; Everhart A; Eling T; Glasgow W
    Biochem Biophys Res Commun; 1997 Feb; 231(1):111-6. PubMed ID: 9070230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic expression of human 15-lipoxygenase (LO)-1 in the dorsolateral prostate of normal wild-type C57BL/6 mouse causes PIN-like lesions.
    Sen M; McHugh K; Hutzley J; Philips BJ; Dhir R; Parwani AV; Kelavkar UP
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):1-13. PubMed ID: 16997127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer.
    Meyer-Siegler KL; Iczkowski KA; Vera PL
    BMC Cancer; 2005 Jul; 5():73. PubMed ID: 16000172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonic and linoleic acid metabolism in mouse intestinal tissue: evidence for novel lipoxygenase activity.
    Kawajiri H; Hsi LC; Kamitani H; Ikawa H; Geller M; Ward T; Eling TE; Glasgow WC
    Arch Biochem Biophys; 2002 Feb; 398(1):51-60. PubMed ID: 11811948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugated linoleic acid, cis-9,trans-11, is a substrate for pulmonary 15-lipoxygenase-1 in rat.
    Cho H; Gallaher DD; Csallany AS
    J Agric Food Chem; 2005 Sep; 53(18):7262-6. PubMed ID: 16131140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
    Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
    Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
    Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
    Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
    Herness EA; Naz RK
    Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
    Dizeyi N; Bjartell A; Nilsson E; Hansson J; Gadaleanu V; Cross N; Abrahamsson PA
    Prostate; 2004 May; 59(3):328-36. PubMed ID: 15042609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.
    Kelavkar UP; Glasgow W; Olson SJ; Foster BA; Shappell SB
    Neoplasia; 2004; 6(6):821-30. PubMed ID: 15720809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens.
    Guo X; Knudsen BS; Peehl DM; Ruiz A; Bok D; Rando RR; Rhim JS; Nanus DM; Gudas LJ
    Cancer Res; 2002 Mar; 62(6):1654-61. PubMed ID: 11912136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events.
    Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS; Kopff HS
    Cancer Res; 1999 Sep; 59(18):4693-701. PubMed ID: 10493527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.